Medacta USA, Inc.
Jim Dulaney is a seasoned professional with extensive experience in the medical device and pharmaceutical sectors. Currently, Jim serves as Senior Director of Strategic Relations at Medacta USA, Inc., and as Principal at The Dulaney Group, focusing on sales leadership and commercial management. Previous roles include Senior Vice President of US Commercialization at Moximed, where Jim prepared for a commercial launch, and Vice President of Commercial Operations & Sales at MicroPort Orthopedics, Inc., where a turnaround of US sales growth was achieved. Notable positions also include Vice President of Sales at Lipogems US and Vice President Sales/Area Director at Crosslink Bioscience, among others. Jim's career commenced as a Sales Representative at Zimmer-Ogburn & Associates, leading to significant revenue growth. Jim holds a Bachelor of Science degree in Exercise Physiology from the University of Tennessee, Knoxville.
This person is not in any teams
Medacta USA, Inc.
2 followers
Medacta USA is a subsidiary of Medacta International, a company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine. Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta’s innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 40 countries. Medacta USA is headquartered in Franklin, Tennessee.